By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Multikinase inhibitors > Stivarga > Stivarga Side Effects
Multikinase inhibitors

Stivarga Side Effects

Note: This document contains side effect information about regorafenib. Some dosage forms listed on this page may not apply to the brand name Stivarga.

Summary

Common side effects of Stivarga include: infection, anemia, asthenia, diarrhea, fatigue, fever, hemorrhage, hyperbilirubinemia, hypertension, hypocalcemia, hypokalemia, hyponatremia, hypophosphatemia, increased amylase, increased inr, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum lipase, lymphocytopenia, mucositis, neutropenia, pain, palmar-plantar erythrodysesthesia, proteinuria, skin rash, thrombocytopenia, voice disorder, weight loss, and decreased appetite. Continue reading for a comprehensive list of adverse effects.

Applies to regorafenib: oral tablet.

Warning

Oral route (Tablet)

Severe and sometimes fatal hepatotoxicity has occurred with regorafenib therapy. Monitor hepatic function prior to and during therapy. Adjust dose or interrupt or discontinue therapy if hepatoxicity occurs.

Serious side effects of Stivarga

Along with its needed effects, regorafenib (the active ingredient contained in Stivarga) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking regorafenib:

More common

  • Bleeding gums
  • bloody or cloudy urine
  • blurred vision
  • cough or hoarseness
  • coughing up blood
  • difficult, burning, or painful urination
  • difficulty with breathing or swallowing
  • dizziness
  • fever or chills
  • frequent urge to urinate
  • headache
  • increased menstrual flow or vaginal bleeding
  • lower back or side pain
  • nervousness
  • nosebleeds
  • painful or difficult urination
  • pounding in the ears
  • prolonged bleeding from cuts
  • rash
  • red or black, tarry stools
  • redness, swelling, or pain of the skin
  • scaling of the skin on the hands and feet
  • slow or fast heartbeats
  • tingling of the hands and feet
  • ulcers on the skin

Less common

  • Chest pain or discomfort
  • dark-colored urine
  • general feeling of tiredness or weakness
  • light-colored stools
  • nausea or vomiting
  • pain or discomfort in the arms, jaw, back, or neck
  • shakiness in the legs, arms, hands, or feet
  • stomach pain that continues
  • sweating
  • yellow eyes or skin

Rare

  • Blistering, peeling, or loosening of the skin
  • bloody, black, or tarry stools
  • chills
  • confusion
  • diarrhea
  • heartburn
  • indigestion
  • itching
  • joint or muscle pain
  • red skin lesions, often with a purple center
  • severe stomach pain, cramping, or burning
  • sore throat
  • sores, ulcers, or white spots in the mouth or on the lips
  • trouble breathing
  • unusual tiredness or weakness
  • vomiting of material that looks like coffee grounds, severe and continuing

Other side effects of Stivarga

Some side effects of regorafenib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Bad, unusual, or unpleasant taste
  • hair loss or thinning of the hair
  • lack or loss of strength
  • muscle or joint stiffness
  • weight loss

Less common

  • Constipation
  • depressed mood
  • dry skin and hair
  • feeling cold
  • muscle cramps
  • weight gain

For Healthcare Professionals

Applies to regorafenib: oral tablet.

Hepatic

Very common (10% or more): Increased AST (93%), hyperbilirubinemia (78%), increased ALT (70%)

Common (1% to 10%): Acute kidney injury

Uncommon (0.1% to 1%): Severe liver injury

Frequency not reported: Hepatic failure[Ref]

Genitourinary

Very common (10% or more): Proteinuria (84%)

Common (1% to 10%): Hyperuricemia[Ref]

Hematologic

Very common (10% or more): Anemia (79%), lymphopenia (68%), thrombocytopenia (63%), increased INR (44%), neutropenia (16%)

Common (1% to 10%): Leukopenia[Ref]

Metabolic

Very common (10% or more): Hypophosphatemia (70%), hypocalcemia (59%), decreased appetite and food intake (47%), weight loss (32%), hypokalemia (31%), hyponatremia (30%), hypothyroidism (18%)

Common (1% to 10%): Hypomagnesemia, hypoalbuminemia[Ref]

Dermatologic

Very common (10% or more): Hand-food skin reaction/palmar-plantar erythrodysesthesia syndrome (67%), rash (30%), alopecia (24%)

Common (1% to 10%): Exfoliative rash, dry skin, nail disorder

Uncommon (0.1% to 1%): Erythema multiforme

Rare (less than 0.1%): Stevens-Johnson Syndrome, toxic epidermal necrolysis, keratoacanthoma/squamous cell carcinoma of the skin[Ref]

Other

Very common (10% or more): Asthenia/fatigue (64%), pain (60%), infection (32%), fever (28%), mucosal inflammation (17%)

Common (1% to 10%): Tinnitus, ear discomfort[Ref]

Cardiovascular

Very common (10% or more): Hypertension (59%), hemorrhage (21%)

Uncommon (0.1% to 1%): Myocardial ischemia, myocardial infarction, hypertensive crisis, acute coronary syndrome[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (47%), increased lipase (46%), mucositis (40%), increased amylase (26%), stomatitis (25%), nausea (20%), vomiting (17%)

Common (1% to 10%): Pancreatitis, gastroesophageal reflux, gastroenteritis, dry mouth

Uncommon (0.1% to 1%): GI fistula, GI perforation[Ref]

Respiratory

Very common (10% or more): Dysphonia (39%)

Common (1% to 10%): Epistaxis[Ref]

Nervous system

Very common (10% or more): Headache (16%)

Common (1% to 10%): Tremor, taste disorder, peripheral sensory neuropathy, vertigo

Frequency not reported: Reversible posterior leukoencephalopathy syndrome/posterior reversible encephalopathy syndrome[Ref]

Musculoskeletal

Very common (10% or more): Muscle spasms (14%), musculoskeletal stiffness (14%)[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity reaction[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by